| Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection V Hall, S Foulkes, F Insalata, P Kirwan, A Saei, A Atti, E Wellington, ... New England Journal of Medicine 386 (13), 1207-1220, 2022 | 649 | 2022 |
| Safety and immunogenicity of novel adenovirus type 26–and modified vaccinia ankara–vectored ebola vaccines: a randomized clinical trial ID Milligan, MM Gibani, R Sewell, EA Clutterbuck, D Campbell, E Plested, ... Jama 315 (15), 1610-1623, 2016 | 399 | 2016 |
| Immune responses to novel adenovirus type 26 and modified vaccinia virus Ankara–vectored Ebola vaccines at 1 year RL Winslow, ID Milligan, M Voysey, K Luhn, G Shukarev, M Douoguih, ... Jama 317 (10), 1075-1077, 2017 | 109 | 2017 |
| Air and surface sampling for monkeypox virus in a UK hospital: an observational study S Gould, B Atkinson, O Onianwa, A Spencer, J Furneaux, J Grieves, ... The Lancet Microbe 3 (12), e904-e911, 2022 | 80 | 2022 |
| Evaluation of the Clinical and Microbiological Response to Salmonella Paratyphi A Infection in the First Paratyphoid Human Challenge Model HC Dobinson, MM Gibani, C Jones, HB Thomaides-Brears, M Voysey, ... Clinical Infectious Diseases 64 (8), 1066-1073, 2017 | 79 | 2017 |
| Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study Lancet Infect Dis, 2022 | 76* | 2022 |
| Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study A Atti, F Insalata, EJ Carr, AD Otter, J Castillo-Olivares, M Wu, R Harvey, ... Journal of Infection 85 (5), 545-556, 2022 | 32 | 2022 |
| Effectiveness and durability of protection against future SARS-CoV-2 infection conferred by COVID-19 vaccination and previous infection; findings from the UK SIREN prospective … V Hall, S Foulkes, F Insalata, A Saei, P Kirwan, A Atti, E Wellington, ... MedRxiv, 2021.11. 29.21267006, 2021 | 22 | 2021 |
| Cross-sectional study of the prevalence, causes and management of hospital-onset diarrhoea D Mawer, F Byrne, S Drake, C Brown, A Prescott, B Warne, R Bousfield, ... Journal of Hospital Infection 103 (2), 200-209, 2019 | 15 | 2019 |
| Early Warning Surveillance for SARS-CoV-2 Omicron Variants, United Kingdom, November 2021–September 2022 S Foulkes, EJM Monk, D Sparkes, N Hettiarachchi, ID Milligan, K Munro, ... Emerging infectious diseases 29 (1), 184, 2023 | 5 | 2023 |
| The Barts Health NHS Trust COVID-19 cohort: characteristics, outcomes and risk scoring of patients in East London T Crocker-Buque, S Williams, AR Brentnall, R Gabe, S Duffy, JR Prowle, ... The International Journal of Tuberculosis and Lung Disease 25 (5), 358-366, 2021 | 3 | 2021 |
| Isolated endogenous Fusarium endophthalmitis in an immunocompetent adult after a thorn prick to the hand AL Milligan, AM Gruener, ID Milligan, GA O'Hara, MR Stanford American Journal of Ophthalmology Case Reports 6, 45-47, 2017 | 3 | 2017 |
| A multinational case series describing successful treatment of persistent severe acute respiratory syndrome coronavirus 2 infection caused by omicron sublineages with prolonged … LB Snell, A McGreal-Bellone, C Nye, S Gage, P Bakrania, TGS Williams, ... Open Forum Infectious Diseases 11 (1), ofad612, 2024 | 2 | 2024 |
| Severe COVID-19 caused by persistent SARS-CoV-2 infection successfully treated with dual direct acting antivirals. LB Snell, P Bakrania, TGS Williams, JCH Tam, DDS Fontoura, E Shaw, ... | 1 | 2022 |
| Severe ocular Mpox in person living with advanced HIV treated with extended course of tecovirimat L Brown, P Sargent, M Islam, C Downie, A Hassan, G O'Hara, ... HIV medicine, 2024 | | 2024 |
